Rentokil Initial Investor Day Presentation Deck

Wellbeing Opportunity Strong and sustained performance Operate in 15 countries under our Ambius brand: Australia, Belgium, Canada, Finland, France, Germany, Ireland, Netherlands, New Zealand, Norway, South Africa, Spain, Sweden, UK and USA. Pre-pandemic total revenue CAGR of c.4% over last five years, revenues of £172m in 2019 delivering average margins of c.14% across that period Opportunities for organic & acquisitive growth ● Targeting growth at 3% + given the increased focus on wellbeing M&A activity will be used selectively to build out the scale of our wellbeing offer in current Ambius markets and also in new markets where we have existing operations. 105

View entire presentation